000 05911nam a22004335i 4500
999 _c330874
_d330874
_x1
001 330874
003 ES-MaUEC
005 20230102114625.0
006 a||||fo|||| 00| 0
007 cr nn nnnaamaa
008 210112s2021 gw | s |||| 0|eng d
020 _a9783030514556
024 7 _a10.1007/978-3-030-51455-6
_2doi
040 _aES-MaUEC
_bspa
_cES-MaUEC
_erda
_dES-MaUEC
050 4 _aRM301.25
_b2021 EB
245 0 0 _aDatabases for Pharmacoepidemiological Research
_cedited by Miriam Sturkenboom, Tania Schink.
250 _aFirst edition 2021
264 1 _aCham, Switzerland
_bSpringer International Publishing
_c2021
300 _a1 recurso en línea (IX, 280 páginas)
_b2 ilustraciones
336 _2rdacontent
_aTexto
_btxt
337 _2rdamedia
_aelectrónico
_bc
338 _2rdacarrier
_arecurso electrónico
_bcr
347 _aArchivo de texto
_bPDF
490 0 _aSpringer Series on Epidemiology and Public Health
_x1869-7933
505 0 _aPart 1 : Databases for Phramacoepidemiological Research -- Chapter 1 - Introduction (Miriam Sturkenboom) -- Chapter 2 - Overview of databases (Iris Pigeot, Maike Tahden, Dimitrios Zampatis, Douglas J. Watson, Ulla Forssen, Bianca Kollhorst) -- Part 2 : Databases in Europe -- Chapter 3 - Clinical Practice Research Datalink (CPRD) (Melissa Myland, Caroline O'Leary, Bassam Bafadhal, Mustafa Dungarwalla, Harshvinder Bhullar, Louise Pinder, James Philpott) -- Chapter 4 - IQVIA Medical Research Data (IMRD) (Caroline O'Leary) -- Chapter 5 - The Health Service Executive - Primary Care Reimbursement Services Database in Ireland (Ireland HSE-PCRS) (Sarah-Jo Sinnott) -- Chapter 6 - Administrative Registers in Finland, Sweden, and Norway (Tuire Prami, Rosa Juuti, Ilona Iso-Mustajärvi) -- Chapter 7 - PHARMO Database Network (Ron Herings, Marina Bakker) -- Chapter 8 - German Pharmacoepidemiological Research Database (GePaRD) (Ulrike Haug, Tania Schink) -- Chapter 9 - Institute for Applied Health Research Berlin (InGef) Database (Frank Andersohn, Jochen Walker ) -- Chapter 10 - National health insurance claims database in France, Système Nationale des Données de Santé (SNDS) and Health Data Hub (HDH) (Nicholas Moore, Patrick Blin, Régis Lassalle, Nicolas Thurin, Pauline Bosco-Levy, Cécile Droz) -- Chapter 11 - Agenzia regionale di sanità della Toscana (ARS) Database (Rosa Gini).-Chapter 12 - Caserta Record Linkage Database (Gianluca Trifirò, Valentina Ientile, Janet Sultana, Michele Tari) -- Chapter 13 - Pedianet Database (Anna Cantarutti) -- Chapter 14 - BIFAP Program: A data resource for Pharmacoepidemiological research in Spain (Miguel Gil, Miguel Angel Maciá, Julio Bonis, Consuelo Huerta, Elisa Martín-Merino, Arturo Álvarez, Verónica Bryant and Dolores Montero on behalf of BIFAP Team) -- Chapter 15 - The Information System for Research in Primary Care (SIDIAP) (Talita Duarte-Salles, María Aragón, Bonaventura Bolíbar) -- Chapter 16 - Estonian Health Insurance Fund (EHIF) Database (Sirly Lätt, Helis Puksand) -- Chapter 17 - Icelandic Medicines Registry (IMR) (Larus S. Gudmundsson, Olafur B. Einarsson, Magnus Johannsson) -- Part 3 : Databases in North America -- Chapter 18 - Régie de l'assurance maladie du Québec (RAMQ) databases (Machelle Wilchesky, Samy Suissa) -- Chapter 19 - Medicaid and Medicare (Dirk Enders, Tania Schink, Til Stürmer) -- Chapter 20 - Truven Health MarketScan Research Databases (MarketScan) (Anne M. Butler, Katelin B. Nickel, Robert A. Overman, M. Alan Brookhart) -- Part 4 : Databases in Asia and Australia -- Chapter 21 - Australian Pharmaceutical Benefits Scheme (PBS) Dispensing Database (Emily A. Karanges, Melisa J. Litchfield, Leigh Mellish, Sallie-Anne Pearson) -- Chapter 22 - National Insurance Claims Database (NDB) (Daisuke Sato, Kazuhiko Ohe).-Chapter 23 - National Health Insurance (NHI) Database (K. Arnold Chan).
520 3 _aThis book allows readers to gain an in-depth understanding of the role of real-world data in pharmacoepidemiology, and highlights the strengths and limitations of the respective databases with regard to pharmacoepidemiological research. Over the past decade, the increasing use of real-world data in pharmacoepidemiological research has been accompanied by a growing recognition of the value of real-world evidence in clinical and regulatory decision-making. Electronic healthcare databases allow analyses of drug and vaccine utilization in routine care after approval, as well as investigations of their comparative effectiveness and safety. They are especially useful for the identification of rare risks and rare drug exposures over long periods of time, and as such sustainably extend the basis for drug safety research. This book provides an introduction to the role of real-world data in pharmacoepidemiological research and the main developments in the last 15 years. It also offers a comprehensive overview of the general classification characteristics of databases, together with their strengths and limitations, and a detailed description of 21 individual databases, written by professionals who work with or maintain them.
988 _aSpringer_Medicine_2021
650 7 _2embne
_9168753
_aMedicamentos
_xEfectos secundarios
700 1 _aSturkenboom, Miriam
_eeditor literario
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
700 1 _aSchink, Tania
_eeditor literario
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
776 0 8 _iPrinted edition:
_z9783030514549
776 0 8 _iPrinted edition:
_z9783030514563
776 0 8 _iPrinted edition:
_z9783030514570
856 4 0 _uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-3-030-51455-6
_zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942 _2lcc
_cLE
_n0
998 _b03/2021
_dz
_ep
_zSI